Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $554.03 million. The enterprise value is -$230.62 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.25 million shares outstanding. The number of shares has increased by 67.48% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.25M |
| Shares Change (YoY) | +67.48% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 40.34% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.17 |
| Forward PS | 15.52 |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.86 |
| Quick Ratio | 14.57 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -258.71 |
Financial Efficiency
Return on equity (ROE) is -37.07% and return on invested capital (ROIC) is -27.03%.
| Return on Equity (ROE) | -37.07% |
| Return on Assets (ROA) | -21.69% |
| Return on Invested Capital (ROIC) | -27.03% |
| Return on Capital Employed (ROCE) | -30.06% |
| Revenue Per Employee | $84,334 |
| Profits Per Employee | -$666,302 |
| Employee Count | 305 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.92% in the last 52 weeks. The beta is 1.41, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -61.92% |
| 50-Day Moving Average | 8.06 |
| 200-Day Moving Average | 13.87 |
| Relative Strength Index (RSI) | 54.58 |
| Average Volume (20 Days) | 304,007 |
Short Selling Information
| Short Interest | 2.60M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 6.84% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.95 |
Income Statement
In the last 12 months, BCYC had revenue of $25.72 million and -$203.22 million in losses. Loss per share was -$3.13.
| Revenue | 25.72M |
| Gross Profit | -171.57M |
| Operating Income | -248.36M |
| Pretax Income | -163.02M |
| Net Income | -203.22M |
| EBITDA | -241.21M |
| EBIT | -248.36M |
| Loss Per Share | -$3.13 |
Full Income StatementBalance Sheet
The company has $792.97 million in cash and $8.33 million in debt, giving a net cash position of $784.65 million or $11.33 per share.
| Cash & Cash Equivalents | 792.97M |
| Total Debt | 8.33M |
| Net Cash | 784.65M |
| Net Cash Per Share | $11.33 |
| Equity (Book Value) | 740.33M |
| Book Value Per Share | 10.70 |
| Working Capital | 798.46M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$180.23 million and capital expenditures -$1.83 million, giving a free cash flow of -$182.05 million.
| Operating Cash Flow | -180.23M |
| Capital Expenditures | -1.83M |
| Free Cash Flow | -182.05M |
| FCF Per Share | -$2.63 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -965.55% |
| Pretax Margin | -811.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.48% |
| Shareholder Yield | -67.48% |
| Earnings Yield | -36.68% |
| FCF Yield | -32.86% |
Analyst Forecast
The average price target for BCYC is $25.00, which is 212.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.00 |
| Price Target Difference | 212.50% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 69.30% |
| EPS Growth Forecast (5Y) | -58.92% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 4.32 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.32 |
| Piotroski F-Score | 2 |
